Insider Trading History of Samsara Biocapital, L.p.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Samsara Biocapital, L.p. since 2023. This trader's CIK number is 1699737. At the time of last reporting, Samsara Biocapital, L.p. was the Officer of Mineralys Therapeutics, Inc.. (stock ticker symbol MLYS). Also see all insider trading activities at Mineralys Therapeutics, Inc..

Note that in the past Samsara BioCapital, L.P. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Mineralys Therapeutics, Inc. (MLYS) by Samsara Biocapital, L.p.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 MLYS 600,000 $8,100,000 0 $0 0 $0
2024 MLYS 555,555 $7,499,992 0 $0 0 $0
2023 MLYS 937,500 $15,000,000 0 $0 0 $0

Yearly summary of insider trading at Scholar Rock Holding Corp (SRRK) by Samsara Biocapital, L.p.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 SRRK 2,189,781 $14,999,999 0 $0 0 $0


Insider trading activities at 2 companies by Samsara Biocapital, L.p.:

1. Mineralys Therapeutics, Inc. (MLYS)

2. Scholar Rock Holding Corp (SRRK)

Table 1. Insider trading of Mineralys Therapeutics, Inc. (MLYS) by Samsara Biocapital, L.p.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-03-13 MLYS Buy 600,000 13.50 8,100,000
2024-02-12 MLYS Buy 555,555 13.50 7,499,992
2023-02-14 MLYS Buy 937,500 16.00 15,000,000

Table 2. Insider trading of Scholar Rock Holding Corp (SRRK) by Samsara Biocapital, L.p.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-10-16 SRRK Buy 2,189,781 6.85 14,999,999

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Samsara Biocapital, L.p. (Officer of Mineralys Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.